AstraZeneca PLC (LON:AZN) has announced its year to date and Q3 2021 results. – Total Revenue in the year to date, including Alexion from 21 July 2021, was $25,406m, representing growth of 32% (28% at CER). Total Revenue in the third quarter increased by 50% (48% at CER) to $9,866m – Excluding the pandemic COVID-19 … Continue reading AstraZeneca’s scientific leadership continues to provide strong revenue growth and exceptional pipeline delivery
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed